Not everything new is wonderful.
When a company improves its operations, it seeks to do so in a way that decreases costs or produces features customers want enough to pay for. It works to ensure that the benefits of adopting new procedures outweigh the costs.
At least, this is what profitable companies do when free to act in accordance with their reason for being.
Government regulations clash with this, however. One of the “we have to pass the bill so that you can find out what is in it” provisions of Obamacare, for example, forces medical practitioners to convert to electronic record-keeping — even if they think the burden unjustified.
A businessman may be wrong about whether to try a new way — and, if he does adopt an innovation, about how fast or thoroughly to adopt it. If he’s wrong, he’s free to change his mind as evidence comes in. But, in medicine, government edict replaces entrepreneurial judgment.
Mandates and prohibitions are already rife in the medical industry; Obamacare makes a bad situation worse. “In today’s health care system,” writes blogger Rituparna Basu, “a doctor’s judgment as to whether it makes sense to adopt a new technology for his practice is deemed irrelevant. The government is the one calling the shots, and jeopardizing doctors’ practices in the process.”
A sound diagnosis.
The prognosis might not be so negative, however. While governments tend to prescribe uniform, one-size-fits-all “cures,” ongoing advances in genetics point the other direction, to individualizing medical practice, finding specific causes of illnesses, and developing genetics-informed, patient-specific cures.
But it’s just possible that individually focused medicine would be enhanced by a healthy dose of individual freedom.
This is Common Sense. I’m Paul Jacob.








